Carregant...
Patently unpatentable: implications of the Myriad court decision on genetic diagnostics
The recent decision in the case Association for Molecular Pathology et al. v. United States Patent and Trademark Office et al. shocked the biotechnology industry. Although the case could be overturned on appeal, it will likely change how gene patents are written. The effects of the decision may be m...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2955823/ https://ncbi.nlm.nih.gov/pubmed/20832881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tibtech.2010.08.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|